AMAGRI

The AMAGRI team is a social science research group working on the regulation, circulation and use of antimicrobials in livestock farming.

[Eleanor Kashouris @EKashouris]

PhD students working on social science of AMR! Join us
@azak_a @crinamoreno @e_rottenburg @MJeleff @IonaWalker in March to read 'With Microbes' @matteringpress, starting with @nfortane chapter on surveillance

[AMAGRI @socioAMAGRI]

Et voici la suite de ce billet sur la trajectoire de la colistine en France ces dernières année ! Dernière partie probablement après les fêtes ;)

https://t.co/Yf2xGaW2FL

[AMAGRI @socioAMAGRI]

Hello ! Heureux de revenir ici à l'occasion de la #WAAW2021 ! On commence par un petit billet sur la trajectoire de la colistine, basé sur une recherche menée cette année sur la non-classification de cette molécule comme antibiotique critique en France.

https://t.co/GEe55q2d81

[AMAGRI @socioAMAGRI]

And here is the second part of this commentary on the trajectory of colistin regulation in France in the last decade ! Last part probably after Xmas ;)

https://t.co/Z4tU0ry1Yr

[AMAGRI @socioAMAGRI]

Hi there ! We're happy to let you know that we're back for #WAAW2021 ! Let's start with a first piece of a little series about colistin, based on a research we did earlier this year asking why France hasn't classified it as a critical antimicrobial.

https://t.co/NLwMYpEzjr

[AMAGRI @socioAMAGRI]

Le lien pour accéder au séminaire est le suivant : https://t.co/KSIftRKRk9

[AMAGRI @socioAMAGRI]

Deuxième séance du séminaire AMAGRI jeudi midi ! Venez écouter parler de marchés et régulations pharmaceutiques, et plus particulièrement ce mois-ci de la gestion des effets indésirables des médicaments (lien dans les commentaires)

https://t.co/Lcsswg7dJc

[AMAGRI @socioAMAGRI]

Geoffrey Carrère (Université de Toulouse) nous parlera de « La mise à l’agenda de la contamination de l’eau par les médicaments en milieu hospitalier : entre éléments contingents, stratégiques et structurels ».

[Esmita Charani @e_charani]

#Antibiotic stories: a mixed-methods, analysis of household 💊 use 🇲🇼 🇺🇬 🇿🇼- drivers for use include:
💊 prominence of donor programmes
💊lack of investment in disease prevention
💊entrenched inequalities | ⁦@GlobalHealthBMJ⁩ 👏🏼 ⁦@AnthroAMR⁩ https://t.co/hFxhgnAbHG

[Microbio-Social Futures @MicroSocFutures]

Antimicrobial resistance drivers are social and economic so let's mobilise social science for #OneHealth solutions to AMR #WAAW #AMRsocsci @ICARS_global @SonarGlobalEU @AnthroAMR https://t.co/n3eS9UiLG3

[ROADMAP @ROADMAP_H2020]

🗓️ 24 November 13:00 CET ➡️Do not miss our webinar on fighting #AMR in animals, with hands-on experiences of #farmers, #vets, pet owners and #breeders on reducing #antimicrobialuse.

@ProjectDisarm @project_avant @HLSProject

[AMAGRI @socioAMAGRI]

Hello ! Heureux de revenir ici à l'occasion de la #WAAW2021 ! On commence par un petit billet sur la trajectoire de la colistine, basé sur une recherche menée cette année sur la non-classification de cette molécule comme antibiotique critique en France.

https://t.co/GEe55q2d81

[AMAGRI @socioAMAGRI]

Hi there ! We're happy to let you know that we're back for #WAAW2021 ! Let's start with a first piece of a little series about colistin, based on a research we did earlier this year asking why France hasn't classified it as a critical antimicrobial.

https://t.co/NLwMYpEzjr

[AMAGRI @socioAMAGRI]

Hi there ! We're happy to let you know that we're back for #WAAW2021 ! Let's start with a first piece of a little series about colistin, based on a research we did earlier this year asking why France hasn't classified it as a critical antimicrobial.

https://t.co/NLwMYpEzjr

[Clare Chandler @AnthroAMR]

Want an easy-access summary of what social research recommends on antibiotic use? Our review is out! #SocSciAMR #AMR @LenoreManderson https://t.co/kMNYCnsEUl

[AntibioticResearchUK @1Antruk]

#AntibioticResistance is going to get worse.

The discovery of new #antibiotics is not economically viable. Trustee Prof Chris Dowson talks to BBC Science Focus on the need for a new approach. @warwick_amr @warwickuni https://t.co/Zlum5kQUPo

[AMAGRI @socioAMAGRI]

Very interesting paper on antibiotics uses and narratives! #antimicrobials #AMR #AMRsocsci

[Microbio-Social Futures @MicroSocFutures]

Great to see this paper from our research group in Health: on antibiotics use in everyday life with @drmarkdmdavis1 Davina Lohm Paul Flowers Andrea Whittaker https://t.co/j3iTr31TI7 @CentreImpactAMR #AMRsocsci

[AMAGRI @socioAMAGRI]

Motion d'objection finalement rejetée par le Parlement européen #antibiotiquescritiques

[SIMV @SIMV_RP]

👏😍 #Antibiorésistance: @SIMV_RP salue le soutien du Parlement européen pour protéger la santé et le bien-être des animaux https://t.co/tpjs18b6Mh

#antimicrobiens #AMR #antibiotiques

[AMAGRI @socioAMAGRI]

A wonderful issue for those interested in the emerging knowledge, practices and government of microbes. A must read for the AMAGRI team and social scientists more generally!

[Charlotte Brives @BrivesCharlotte]

Open Access special issue on human/microbes relations! In french, but the intro is also available in english and spanish.
https://t.co/YtiJIu6N8y
Our own paper with @FroissartRemy, already available in French, will also be available in english very soon!
https://t.co/ceFQxnoOqM

[AMAGRI @socioAMAGRI]

Mobilisation des stakeholders sur un acte délégué du paquet vétérinaire de 2019. #antibiotiquescritiques

[EPRUMA @epruma1]

As of this morning over 9⃣0⃣0⃣0⃣ parties have signed our Open Letter calling on MEPs to support the scientific advice in the COM Delegated Act on reserve antibiotics
❌And reject the Motion for a Resolution

Read the Open Letter: https://t.co/W2a1AQ65tN

[AMAGRI @socioAMAGRI]

Actualité brûlante sur les listes d'antibiotiques critiques et leurs critères de classement! Une belle enquête pour le projet AMAGRI! 🔍🤓📚

[Julien Denormandie @J_Denormandie]

En total accord avec @SKyriakidesEU, et plein soutien à la tribune des docteurs vétérinaires

https://t.co/OXBrzZRQUS

[AMAGRI @socioAMAGRI]

@MassardGuilbaud Oui le hardback est (très) cher, mais le eBook est disponible pour une trentaine d'euros - ce qui est pour le coup relativement classique!